Yield10 Bioscience Stock Today

Yield10 Bioscience is selling at 0.015 as of the 20th of March 2025; that is No Change since the beginning of the trading day. The stock's open price was 0.015. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Valuation
Check how we calculate scores

Yield10 Stock Highlights

President CEO, DirectorOliver Peoples
Business ConcentrationHealth Care, Biotechnology, Agricultural Inputs, Basic Materials (View all Sectors)
Yield10 Bioscience (YTEN) is traded on NASDAQ Exchange in USA and employs 29 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 345.46 K. Yield10 Bioscience conducts business under Biotechnology sector and is part of Health Care industry. The entity has 692.68 K outstanding shares of which 60.7 K shares are at this time shorted by private and institutional investors with about 0.03 trading days to cover. Yield10 Bioscience currently holds about 10.16 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Yield10 Bioscience Probability Of Bankruptcy

Yield10 Bioscience Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Yield10 Bioscience market risk premium is the additional return an investor will receive from holding Yield10 Bioscience long position in a well-diversified portfolio.

Yield10 Stock Against Markets

View Yield10 Bioscience Related Equities

 Risk & Return  Correlation

Already Invested in Yield10 Bioscience?

The danger of trading Yield10 Bioscience is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Yield10 Bioscience is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Yield10 Bioscience. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Yield10 Bioscience is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.